Companies: 10,795·Total market cap: $144.5T
Lantern Pharma Inc.

Lantern Pharma Inc.

LTRNNASDAQHealthcare● Active
$4.14
+$0.39(+10.27%)
Market Cap$52757936
P/E Ratio—
52W High$5.744
52W Low$1.11
SEC Filings

Lantern Pharma Inc. (LTRN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001763950 · LTRN · NASDAQ · as of Jun 10, 2026

Filing snapshot

246
Total Filings
8-K
Latest Form
2026-06-02
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001763950 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-30
Fiscal Year End
Apr 30, 2026
Accession No.
0001493152-26-019713
Primary Document
form10-ka.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001763950 · Accession 0001493152-26-019713

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-15
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-02Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-02
View
DD
D
2026-05-21
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-05-15
View
8-KCurrent Report
8-K
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-15
View
8-KCurrent Report
8-K
2026-05-14
View
424B5424B5
424B5
2026-05-14
View
10-K/AAnnual Report (Amended)
10-K/A
2026-04-30
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-16
View
8-KCurrent Report
8-K
2026-04-10
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-03
View
424B5424B5
424B5
2026-03-30
View
10-KAnnual Report
10-K
2026-03-30
View
8-KCurrent Report
8-K
2026-03-30
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-02-23
View
Showing 1–15 of 168 filingsForm 4 / 144 hidden· 246 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001763950  |  Exchange: NASDAQ · Healthcare

Lantern Pharma Inc. (NASDAQ: LTRN) has submitted 246 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001763950, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Lantern Pharma Inc.'s most comprehensive regulatory disclosure. The most recent Lantern Pharma Inc. 10-K was filed on 2026-04-30 for fiscal year ending 2026. Historical LTRN 10-K annual reports are available from 2019 through 2026.

Investors researching Lantern Pharma Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
MAIA SEC Filings →LVTX SEC Filings →ELUT SEC Filings →ANVS SEC Filings →ATNM SEC Filings →RNXT SEC Filings →TVRD SEC Filings →CALC SEC Filings →
→ LTRN Financials→ LTRN Earnings→ LTRN Insider Trades

Frequently Asked Questions

LTRN SEC Filings · 8 questions

Lantern Pharma Inc. (LTRN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 246 filings and access original documents at no cost. Lantern Pharma Inc.'s CIK is 0001763950.

LTRN SEC filingsLantern Pharma Inc. SEC documentsfind LTRN 10-K